Description
BEXSERO(MENINGOCOCCAL GROUP B)KIT 1 VACCINE
BEXSERO is a recombinant vaccine that protects against meningococcal disease caused by Neisseria meningitidis group B (MenB). This serious infection can lead to meningitis and septicemia, both of which can be life-threatening. The vaccine targets individuals aged 10 to 25, a group more likely to face exposure due to close contact in schools, universities, or travel.
Healthcare providers give BEXSERO through an intramuscular injection. It follows either a two-dose or three-dose schedule, depending on the person’s age and risk level. The vaccine is especially recommended for teenagers, university students, travelers, and people living in areas with frequent outbreaks.
BEXSERO helps the immune system build strong defenses by creating antibodies that fight MenB bacteria. Most people tolerate the vaccine well. Common side effects include mild fever, soreness at the injection site, tiredness, and irritability.
Thanks to its focused protection and strong safety record, BEXSERO plays a key role in preventing meningococcal group B infections. It gives peace of mind to families and communities by reducing the risk of severe illness in young people.
